Sign in

CIK 0001479419

  • Non-accelerated filer
  • Smaller reporting company

KALA BIO, Inc.

Sign in to watch
Ticker
KALA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
270604595
Phone
+1 781-996-5252
Business address
1167 MASSACHUSETTS AVENUE, ARLINGTON, MA, 02476
Former names
KALA BIO, Inc., Kala Pharmaceuticals, Inc.
  1. 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 198 shares at $28.54 ($5,651)
  2. 4 Derivatives Options or other derivatives
  3. 3 Insider Initial Statement of Ownership
  4. 4 Open-market sale Trachtenberg Eric sold 194 shares at $6.52 ($1,265)
  5. 4 Open-market sale Bazemore Todd sold 214 shares at $6.51 ($1,393)
  6. 4 Open-market sale CHIEF FINANCIAL OFFICER sold 194 shares at $6.51 ($1,263)
  7. 4 Open-market sale Brazzell Romulus K sold 261 shares at $6.51 ($1,699)
  8. 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 561 shares at $6.52 ($3,658)
  9. 4 Open-market sale Trachtenberg Eric sold 2,613 shares at $0.37 ($967)
  10. 4 Open-market sale CHIEF FINANCIAL OFFICER sold 2,613 shares at $0.37 ($967)
  11. 4 Open-market sale Brazzell Romulus K sold 3,144 shares at $0.37 ($1,163)
  12. 4 Open-market sale Bazemore Todd sold 3,092 shares at $0.37 ($1,144)
  13. 4 Open-market sale CHIEF EXECUTIVE OFFICER sold 7,975 shares at $0.37 ($2,951)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Open-market sale 10% owner sold 1,005,686 shares at $0.36 ($365,667)

Page 6 of 15 · 288 filings